Total Payments
$2,016
2024 Payments
$551.93
Companies
24
Transactions
95
Medicare Patients
1,599
Medicare Billing
$119,119
Payment Breakdown by Category
Food & Beverage$1,916 (95.0%)
Education$99.95 (5.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,916 | 94 | 95.0% |
| Education | $99.95 | 1 | 5.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $294.13 | 5 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $220.61 | 8 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $212.03 | 16 | $0 (2024) |
| Amgen Inc. | $185.03 | 12 | $0 (2023) |
| PFIZER INC. | $179.70 | 15 | $0 (2024) |
| Boston Scientific Corporation | $131.63 | 4 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $98.25 | 3 | $0 (2021) |
| Impulse Dynamics (USA) Inc. | $86.17 | 1 | $0 (2023) |
| Medtronic, Inc. | $77.40 | 3 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $76.24 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $551.93 | 26 | Novartis Pharmaceuticals Corporation ($141.00) |
| 2023 | $421.58 | 17 | Actelion Pharmaceuticals US, Inc. ($132.03) |
| 2022 | $526.05 | 28 | PFIZER INC. ($118.70) |
| 2021 | $516.45 | 24 | AstraZeneca Pharmaceuticals LP ($159.31) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $36.72 | General |
| Category: Transcatheter Valve Systems | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $8.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Obesity | ||||||
| 10/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Obesity | ||||||
| 10/09/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/08/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/02/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Transcatheter Valve Systems | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $3.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $3.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/30/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $0.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/13/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $33.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/18/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $14.19 | General |
| Category: Heart Failure and Hypertension | ||||||
| 03/21/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/20/2024 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $39.74 | General |
| Category: Transcatheter Heart Valves | ||||||
| 03/19/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Transcatheter Valve Systems | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 408 | 496 | $105,627 | $19,214 |
| 2022 | 6 | 465 | 583 | $86,374 | $25,033 |
| 2021 | 5 | 388 | 752 | $126,896 | $45,709 |
| 2020 | 6 | 338 | 547 | $90,514 | $29,163 |
Total Patients
1,599
Total Services
2,378
Medicare Billing
$119,119
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 125 | 131 | $47,553 | $9,594 | 20.2% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 46 | 79 | $31,284 | $4,002 | 12.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 43 | $11,008 | $2,231 | 20.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 17 | 20 | $7,260 | $1,222 | 16.8% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 44 | 77 | $5,775 | $1,024 | 17.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 65 | 77 | $539.00 | $528.22 | 98.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 12 | $1,296 | $369.84 | 28.5% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 57 | 57 | $912.00 | $243.09 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 118 | 136 | $31,552 | $10,471 | 33.2% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2022 | 56 | 96 | $27,456 | $6,915 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 117 | 121 | $19,118 | $5,386 | 28.2% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2022 | 59 | 98 | $5,684 | $1,636 | 28.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 38 | 40 | $1,920 | $351.60 | 18.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 77 | 92 | $644.00 | $272.31 | 42.3% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2021 | 141 | 320 | $91,520 | $34,204 | 37.4% |
| 93297 | Remote evaluations of implantable heart and blood vessel monitor system with qualified health care professional analysis, review, and report, up to 30 days | Office | 2021 | 141 | 320 | $18,560 | $5,538 | 29.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 33 | $7,656 | $2,781 | 36.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 44 | $6,952 | $2,592 | 37.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 13 | 13 | $2,054 | $527.40 | 25.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 18 | 22 | $154.00 | $66.00 | 42.9% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2020 | 98 | 200 | $57,200 | $20,358 | 35.6% |
| 93297 | Remote evaluations of implantable heart and blood vessel monitor system with qualified health care professional analysis, review, and report, up to 30 days | Office | 2020 | 97 | 198 | $11,484 | $3,505 | 30.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 20 | 20 | $4,640 | $1,417 | 30.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 38 | 42 | $6,636 | $1,375 | 20.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 29 | 29 | $4,582 | $1,213 | 26.5% |
About Beth Brey, APRN
Beth Brey, APRN is a Acute Care healthcare provider based in Lincoln, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104914282.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Beth Brey, APRN has received a total of $2,016 in payments from pharmaceutical and medical device companies, with $551.93 received in 2024. These payments were reported across 95 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,916).
As a Medicare-enrolled provider, Brey has provided services to 1,599 Medicare beneficiaries, totaling 2,378 services with total Medicare billing of $119,119. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Acute Care
- Other Specialties Adult Health
- Location Lincoln, NE
- Active Since 10/11/2006
- Last Updated 02/01/2012
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1104914282
Products in Payments
- FARXIGA (Drug) $264.60
- OPSUMIT (Drug) $220.61
- Repatha (Biological) $167.49
- ENTRESTO (Drug) $113.21
- VYNDAQEL (Drug) $107.59
- WATCHMAN Access System (Device) $101.83
- LEQVIO (Drug) $98.82
- JARDIANCE (Drug) $98.25
- ELIQUIS (Drug) $86.40
- OPTIMIZER (Device) $86.17
- COREVALVE EVOLUT R (Device) $77.40
- Kerendia (Drug) $76.24
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $69.79
- MULTAQ (Drug) $60.64
- Vascepa (Drug) $53.83
- VERQUVO (Drug) $52.61
- Impella (Device) $33.94
- Wegovy (Drug) $32.30
- XARELTO (Drug) $31.16
- BRILINTA (Drug) $29.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Lincoln
William Saalfeld, Dnp, Aprn, DNP, APRN
Acute Care — Payments: $94,321
Acute Care $94,321
Brooke Donahue, Msn, Ag-Acnp-Bc, MSN, AG-ACNP-BC
Acute Care — Payments: $7,940
Acute Care $7,940
Megan Stitt, Aprn, APRN
Acute Care — Payments: $4,488
Acute Care $4,488
Allison Taskin, Agacnp-Bc, AGACNP-BC
Acute Care — Payments: $3,202
Acute Care $3,202
Vicki Norton, Aprn, Bc, APRN, BC
Acute Care — Payments: $2,789
Acute Care $2,789
Simone Martin, Aprn, APRN
Acute Care — Payments: $1,712
Acute Care $1,712